Brazil
As a Medical Science Liaison specialized Solid Tumors, I bridge the interface between cutting-edge science and clinical application. My role centers on fostering scientific exchange with key opinion leaders, supporting evidence-based therapeutic strategies, and contributing to the medical and strategic imperatives of the oncology portfolio. I hold a Bachelor's degree in Biological Sciences, and both a Master’s and Ph.D. in Genetics and Biochemistry. My graduate and doctoral research was devoted to the rational design and biological evaluation of novel antitumor metal-based complexes specifically copper(II) coordination compounds, as well as the development of nanostructured lipid carriers (NLCs) to optimize drug delivery mechanisms. This academic foundation has equipped me with a deep understanding of molecular oncology, pharmacodynamics, and translational science-core elements that I apply daily in my work as an MSL. I am driven by scientific rigor, collaborative engagement, and the pursuit of innovative solutions that advance patient outcomes in oncology!
• Supported the launch of a next-gen TKI molecule for refractory mCRC patients in Brazil. • Maintained scientific communication with KOLs and stakeholders regarding ALK-positive NSCLC treatments. • Facilitated EAP programs and organized scientific medical events for HCP education. • Collaborated with cross-functional teams to enhance scientific education across the pharmaceutical industry.
• Delivered comprehensive lessons on Genetics, Biochemistry, and Pharmacology to undergraduate students. • Fostered an engaging learning environment for Agronomic Engineering and Veterinary Medicine programs. • Developed course materials and assessments to enhance student understanding and performance. • Collaborated with faculty to improve curriculum and academic standards at UNIPAC.
- Research and development of a chemotherapeutic drug candidate. - Drug's MOA - In vitro and In vivo assays - Preclinical tests - Scientific communication - Oncology - Cancer Biology
- Cytogenetic studies to characterize the oncogenic process. - Screening of copper metallocomplexes with chemotherapeutic properties.